Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer
- PMID: 18165625
- DOI: 10.1634/theoncologist.12-12-1467
Clinical utility of continuing trastuzumab beyond brain progression in HER-2 positive metastatic breast cancer
Comment on
-
Central nervous system metastases in HER-2 positive metastatic breast cancer patients treated with trastuzumab: incidence, survival, and risk factors.Oncologist. 2007 Jul;12(7):766-73. doi: 10.1634/theoncologist.12-7-766. Oncologist. 2007. PMID: 17673608
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
